Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $6000.0.

  • Cross Country Healthcare's Gains from Investment Securities changed 0.0% to $6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 4073.33%. This contributed to the annual value of $3.0 million for FY2024, which is 3964.11% down from last year.
  • Cross Country Healthcare's Gains from Investment Securities amounted to $6000.0 in Q3 2025, which was down 0.0% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Gains from Investment Securities ranged from a high of $5.0 million in Q1 2022 and a low of -$202000.0 during Q1 2025
  • Its 5-year average for Gains from Investment Securities is $1.2 million, with a median of $243500.0 in 2022.
  • In the last 5 years, Cross Country Healthcare's Gains from Investment Securities surged by 78695.65% in 2021 and then crashed by 10746.49% in 2025.
  • Cross Country Healthcare's Gains from Investment Securities (Quarter) stood at $204000.0 in 2021, then rose by 17.16% to $239000.0 in 2022, then tumbled by 94.56% to $13000.0 in 2023, then tumbled by 53.85% to $6000.0 in 2024, then changed by 0.0% to $6000.0 in 2025.
  • Its Gains from Investment Securities stands at $6000.0 for Q3 2025, versus $2.0 million for Q2 2025 and -$202000.0 for Q1 2025.